Hvis der diagnosticeres PRCA, skal Retacrit- terapien straks ophøre, og det skal overvejes at teste for antistoffer mod erytropoietin.
If PRCA is diagnosed, therapy with Retacrit must be immediately discontinued and testing for erythropoietin antibodies should be considered.